Nanosilver and Global Public Health: International Regulatory Issues

Nanomedicine, Vol. 5, No. 4, pp. 617-632, 2010

ANU College of Law Research Paper No. 10-48

17 Pages Posted: 16 Jun 2010 Last revised: 30 Jul 2010

See all articles by Thomas Alured Faunce

Thomas Alured Faunce

Australian National University

Aparna Watal

affiliation not provided to SSRN

Abstract

Silver in nanoparticle form is used extensively worldwide in hospital and general practice settings in dressings as a treatment for external wounds, burns, and ulcers. Nanosilver also is an increasingly important coating over embedded medical devices, inhibiting the development of biofilm. Nanosilver disinfectant sprays and polymer coatings are being widely promoted as protective against viral infections. Nanosilver additionally is widely used for its anti-bacterial properties in food processing and packaging, as well as consumer products used for domestic cleaning and clothing.

This article argues that medical devices, therapeutic products and domestic food and goods containing nanosilver, though offering therapeutic benefits, must be subject to precautionary regulation because of associated public health and environmental risks, particularly from large volumes of nanosilver in waste water. It first examines the use of nanosilver in a variety of contemporary medical and domestic products and this utilization may assist in resolving global public health problems such as restricted access to safe food, water and medical care. It then discusses the mechanisms of toxicity for nanosilver, whether it should be classified as a new chemical entity for regulatory purposes and whether its increased usage poses significant environmental and public health risks. The article next critically analyses representative international regulatory regimes (the United States, European Union, United Kingdom and Australia) for medical and domestic use of nanosilver. The conclusion includes a set of recommendations for improving international regulation of nanosilver in terms of both its safety and potential positive contribution to global public health. Author's proof copy.

Keywords: Nanosilver, Nanotechnology, Nanomedicine, Nanotoxicology, Public Health, Health Technology Regulation

JEL Classification: D63, D81, I18, K32, L65

Suggested Citation

Faunce, Thomas Alured and Watal, Aparna, Nanosilver and Global Public Health: International Regulatory Issues. Nanomedicine, Vol. 5, No. 4, pp. 617-632, 2010, ANU College of Law Research Paper No. 10-48, Available at SSRN: https://ssrn.com/abstract=1625548

Thomas Alured Faunce (Contact Author)

Australian National University ( email )

Canberra, Australian Capital Territory 0200
Australia
61 2 61253563 (Phone)

Aparna Watal

affiliation not provided to SSRN

Do you have negative results from your research you’d like to share?

Paper statistics

Downloads
218
Abstract Views
1,590
Rank
253,923
PlumX Metrics